Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Total expenses rose 16.45% YoY to Rs 147.45 crore during the quarter. Employee benefits expenses stood at Rs 33 crore (up 14.9%), while the cost of materials consumed was at Rs 55.41 crore (up 24.1% YoY) during the period under review.
The company's revenue from Diagnostic Testing Services was at Rs 178.33 crore (up 24.52% YoY), while revenue from Imaging Services stood at Rs 14.04 crore (up 7.67% YoY) in Q1 FY26.
Reported EBITDA improved 37% YoY to Rs 57.46 crore in the June 2025 quarter from Rs 42.01 crore reported in the corresponding period the previous year. EBITDA margin increased to 30% in Q1 FY26 compared to 27% reported in the corresponding quarter last fiscal year.
Meanwhile, the company announced the appointment of Vikram Gupta as the chief financial officer (CFO) of the company, effective from 24 July 2025.
The counter hit a 52-week high of Rs 1,356.95 in intraday today.
Thyrocare Technologies is engaged in the business of the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories, and hospitals in India.